Skip to main content
. 2017 May 7;8(30):49380–49394. doi: 10.18632/oncotarget.17673

Figure 1. Effects of tunicamycin on the viability of human ovarian cancer cells determined by MTT assay.

Figure 1

(A) Cell viability of different cell lines using 1 mg/L tunicamycin after 24 h; *P < 0.05 compared with the SKOV3 cells. (B) SKOV3 cell viability using different concentrations of tunicamycin (0, 0.5, 1, 1.5 mg/L); Tun, tunicamycin; *P < 0.05 compared with the 0 mg/L group at the same time; ΔP < 0.05 compared with the same concentration group after 12 h. ^P < 0.05 compared with the same concentration group after 24 h; #P < 0.05 compared with the same concentration group after 48 h. The experiments were performed three times and the average values were obtained.